Located within the boundaries of Tekirdaг, Ulkar Kimya is a joint-stock company of Ulkar Holding and is specialized in the manufacture of drug substance and coated mikropellets.
Ulkar Kimya started producing active drug ingredients in 1988 and subsequently, after building a separate plant, it began to produce mikropellets in 2001.
In 2005, it decided to expand its production facilities and laboratories in order to be able to meet increasing demands by the clients. Within this context, its new Quality Control Laboratories were put into operation in 2007 and it completed the new drug substance production plant at the end of 2009.
"How much importance the company gives to quality, safety, health, environmental health and occupational health is evidenced by the fact that our facilities have been endorsed by the Ministry of Health and BfArM Germany," claims the company.
While Ulkar Kimya provides services to other subsidiaries of Ulkar Holding on the one hand, it exports active drug substance and coated mikropellets to European, CIS, Asian, and South and North American countries on the other.
The Company’s line covers products for gastric and intestinal diseases (pyrazoles), for cardiovascular diseases (statins), and for hypertension (sartans). Besides production activities, Ulkar Kimya runs a research and development laboratory with a modern infrastructure and it also carries on activities for developing new molecules.
LATEST issue 4/2019
The European distributor and supply chain management company Orbico has launched a pilot project to deploy Gideon Brothers’ collaborative autonomous mobile robots in their warehouse facilities in Croatia...
The Japanese Toyo Tire Corporation announced its plans to establish a subsidiary in the Republic of Serbia. IoT will be fully installed at this plant, which will operate as a sophisticated smart factory...